This risky biotech company faces significant challenges ahead. But it has already proven its worth and may be able to do so ...

MRNA's second-quarter results are likely to spotlight a sharp decline in Spikevax sales, RSV uptake and key pipeline ...

Sound more like science fiction than actual science? Then, brace yourself because there are, at least, 15 breast cancer vaccine clinical trials in various stages in the U.S., some in phase II and III.

Eli Lilly's appeal of a decision by the EMA's human medicines committee not to approve its Alzheimer's disease therapy ...

Seattle media misrepresent declining vaccination rates among K-12 students in Washington state. Get the facts here.